Longeveron Earnings
NASDAQ: LGVNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.48+0.11 (+4.64%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Tue, Nov 3, 2026
Fiscal period
Sep/2026
EPS estimate
$-1.70
Longeveron earnings summary
Longeveron is scheduled to report Sep/2026 earnings on Nov 3, 2026, with analysts expecting EPS of $-1.70.
Summary generated from market data by MetaCap's automated system. Methodology